Nov 30, 2017 12:40 pm UTC| Business
NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Illumina, Inc....
Nov 30, 2017 12:40 pm UTC| Business
NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of SeaWorld...
Nov 30, 2017 12:30 pm UTC| Business
Retrospective Analyses of Clinical Trials in ALS Shows Faster Rate of Decline in Slow Vital Capacity Strongly Predicts Increased Risk of Future Clinical Events SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 --...
Nov 30, 2017 12:30 pm UTC| Business
Next Generation Fast Skeletal Muscle Activator Appears Promising Compared to Tirasemtiv in Studies of Healthy Volunteers SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 -- Cytokinetics, Incorporated (Nasdaq:CYTK) today...
Nov 30, 2017 12:30 pm UTC| Business
RANCHO CORDOVA, Calif., Nov. 30, 2017 -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Joe Balagot,...
Nov 30, 2017 12:30 pm UTC| Business
NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alliance Data...
Nov 30, 2017 12:30 pm UTC| Business
NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of T-Mobile US,...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update